ECTRIMS 2022: Early Nondisabling Relapses Tied to Risk for Disability Accumulation in Relapsing-Remitting MS
Authors say nondisabling relapses should be taken into consideration when making treatment decisions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.